Although cytotoxic CD8+ T-cells can trigger anti-tumor immune responses, their activity is inhibited by regulatory T cells (Tregs) and immunosuppressive cytokines such as IL-10 and TGF-β. This evidence concerns the gene IL10 and neoplasm.